Kevin Conroy was named to the Abbott Laboratories Board of Directors on April 24, 2026. His appointment was reported in Abbott's Form 8-K filed April 27, 2026; no additional biographical information is provided in the source filings.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.